U.S. Farmers Seen as Major Linchpin to U.S.-Asia Trade
U.S. farmer associations push for more trade deals in Senate hearing on agriculture.
Why Does “Environmental Justice” Only Matter for U.S. Solar, Not SE Asian?
The White House says more solar imports will help spread environmental justice in the U.S. Is Southeast Asia our new Environmental Justice League?
U.S. Challenges in EV Battery Production
By Amanda Mayoral The U.S. is lagging behind China and the European Union in production of lithium-ion batteries for electric vehicles. Forecasts show the
Following Solar Debacle, Republicans Come Out Swinging on China
The Republican-led China Task Force held an impromptu meeting Wednesday, where they backed stronger export and capital controls if they win back the House.
Biden Overthrows Normal Anti-Dumping Procedures to Make U.S. More Dependent on Chinese Solar
President Biden’s Executive Order to waive solar tariffs on Southeast Asia effectively puts an existing trade case against those countries on hold.
U.S. Trade Deficit Eases in April, Down 19.1% to $87.1 Billion
The trade deficit fell. But the January-April goods deficit is still another record breaker.
Biden Just Went Against His Voters, Sided with China on Solar
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
Leading Customs Authorities Make The Case Against De Minimis Commerce
Leading customs authorities make the case against de minimis commerce By Charles Benoit, CPA Trade Counsel “De minimis” treatment for imports, which is available if
FDA’s Updated Drug Shortage List Loaded with Critical Medicines
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senate Puts FDA Re-authorization Deal in Jeopardy Over Infant Formula Crisis
Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.
